Rate of MetS Unchanged after One Year of GH Replacement

August 7, 2018

By Gregory M. Weiss, MD

Slideshow

Results of a new study highlight the importance of intensive treatment of all comorbidities associated with adult growth hormone deficiency.

Recent Videos

Brendon Neuen, MBBS, PhD | Credit: X.com

HCPLive Five at ADA 2024 | Image Credit: HCPLive

Ralph DeFronzo, MD | Credit: UT San Antonio

Timothy Garvey, MD | Credit: University of Alabama at Birmingham

Atul Malhotra, MD | Credit: Kyle Dykes; UC San Diego Health

Optimizing Diabetes Therapies with New Classifications

Should We Reclassify Diabetes Subtypes?

Roger S. McIntyre, MD: GLP-1 Agonists for Psychiatry?

Daniel Gaudet, MD, PhD | Credit: American College of Cardiology

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.